(Q48673097)

14 February 2018

title

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study (English)

1 reference

14 February 2018

author name string

F Olivennes

1

1 reference

14 February 2018

C M Howies

2

1 reference

14 February 2018

A Borini

3

1 reference

14 February 2018

M Germond

4

1 reference

14 February 2018

G Trew

5

1 reference

14 February 2018

M Wikland

6

1 reference

14 February 2018

F Zegers-Hochschild

7

1 reference

14 February 2018

H Saunders

8

1 reference

14 February 2018

V Alam

9

1 reference

14 February 2018

publication date

1 February 2011

1 reference

14 February 2018

Reproductive BioMedicine Online

published in

1 reference

14 February 2018

volume

22 Suppl 1

1 reference

14 February 2018

page(s)

S73-82

1 reference

14 February 2018

Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A model for follicular selection and ovulation: lessons from superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Evidence-based clinical outcome of oocyte slow cooling

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Cumulative pregnancy rates resulting from the use of fresh and frozen oocytes: 7 years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A systematic review of tests predicting ovarian reserve and IVF outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Cryopreservation: the problem of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Cryopreservation of supernumerary oocytes in IVF/ICSI cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Live-birth rates and multiple-birth risk using in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Factors that affect outcome of in-vitro fertilisation treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

What is the most relevant standard of success in assisted reproduction?: The value of cryopreservation on cumulative pregnancy rates per single oocyte retrieval should not be forgotten.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Common statistical errors in the design and analysis of subfertility trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Optimum number of oocytes for a successful first IVF treatment cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Delaying childbearing: effect of age on fecundity and outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960012-6

7 January 2021

10.1016/S1472-6483(11)60012-6

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018